Cell and gene manufacturing requires small batch sampling to preserve the quality and availability of the end therapy for the patient. Sampling must also be performed in a way that facilitates both repeatable outcomes and compliance with regulatory standards. The best way to ensure this is through a sampling process preformed using an aseptic (closed) system. Many sampling procedures today are open and, therefore, subject the entire process to contamination.
A closed system solution utilizing single-use technologies like the Avantor OmniTop Sample Tubes™ adjustable volume sampling system (AVSS) provides an aseptic solution to what is otherwise an open sampling process. This minimizes contamination risk to critical cell and gene therapies. In addition to minimizing risk, the OmniTop Sample Tubes™ AVSS can also help optimize biopharma production processes by reducing sample size errors (over-sampling) and volume loss.
Adopting innovative single-use solutions for in-process sampling ensures more efficient, reliable cell and gene therapy production. The end result? Faster delivery of more dependable treatments to patients.